148 related articles for article (PubMed ID: 8374577)
1. Hepatic complications after bone marrow transplantation.
Mieli-Vergani G
Bone Marrow Transplant; 1993; 12 Suppl 1():96-7. PubMed ID: 8374577
[No Abstract] [Full Text] [Related]
2. Cytokines in veno-occlusive disease of the liver after bone marrow transplantation.
Remberger M; Ringdén O
Transplant Proc; 1995 Dec; 27(6):3533-4. PubMed ID: 8540087
[No Abstract] [Full Text] [Related]
3. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.
Schlitt HJ; Tischler HJ; Ringe B; Raddatz G; Maschek H; Dietrich H; Kuse E; Pichlmayr R; Link H
Bone Marrow Transplant; 1995 Sep; 16(3):473-8. PubMed ID: 8535323
[TBL] [Abstract][Full Text] [Related]
4. Hepatic complications of bone marrow transplantation.
Sale GE
Prog Clin Biol Res; 1989; 309():349-56. PubMed ID: 2675103
[No Abstract] [Full Text] [Related]
5. [Hepatic complications of bone marrow transplantation].
Martí Carvajal A
G E N; 1991; 45(4):329-34. PubMed ID: 1843969
[TBL] [Abstract][Full Text] [Related]
6. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 19-1996. Multisystem failure in a 33-year-old man after bone marrow transplantation.
N Engl J Med; 1996 Jun; 334(25):1655-62. PubMed ID: 8628363
[No Abstract] [Full Text] [Related]
7. Liver dysfunction in the early post-bone marrow transplant period.
Storek J
Cas Lek Cesk; 1996 May; 135(10):295-8. PubMed ID: 8697490
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic bone marrow transplantation: acute and late complications.
Tabbara IA
Anticancer Res; 1996; 16(2):1019-26. PubMed ID: 8687093
[TBL] [Abstract][Full Text] [Related]
9. [Percutaneous intrahepatic portosystemic shunting in the treatment of veno-occlusive disease of the liver after bone marrow transplantation].
Alvarez R; Bañares R; Casariego J; Echenagusía A; Simó G; Alvarez E; Serrano D; Díez-Martín JL
Gastroenterol Hepatol; 2000 Apr; 23(4):177-80. PubMed ID: 10863859
[TBL] [Abstract][Full Text] [Related]
10. Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
Klaesson S; Ringdén O; Ljungman P; Aschan J; Hägglund H; Winiarski J
Transplantation; 1995 Dec; 60(11):1225-30. PubMed ID: 8525515
[TBL] [Abstract][Full Text] [Related]
11. Fulminant adenovirus hepatitis after allogeneic bone marrow transplantation.
Bertheau P; Parquet N; Ferchal F; Gluckman E; Brocheriou C
Bone Marrow Transplant; 1996 Feb; 17(2):295-8. PubMed ID: 8640184
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation.
Azoulay D; Castaing D; Lemoine A; Hargreaves GM; Bismuth H
Bone Marrow Transplant; 2000 May; 25(9):987-92. PubMed ID: 10800068
[TBL] [Abstract][Full Text] [Related]
13. Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation.
Dowlati A; Honore P; Damas P; Deprez M; Delwaide J; Fillet G; Beguin Y
Transplantation; 1995 Jul; 60(1):106-9. PubMed ID: 7624933
[No Abstract] [Full Text] [Related]
14. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study.
Lau GK; Liang R; Chiu EK; Lee CK; Lam SK
Bone Marrow Transplant; 1997 Apr; 19(8):795-9. PubMed ID: 9134171
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.
Rozman C; Carreras E; Qian C; Gale RP; Bortin MM; Rowlings PA; Ash RC; Champlin RE; Henslee-Downey PJ; Herzig RH; Hinterberger W; Klein JP; Prentice HG; Reiffers J; Zwaan FE; Horowitz MM
Bone Marrow Transplant; 1996 Jan; 17(1):75-80. PubMed ID: 8673059
[TBL] [Abstract][Full Text] [Related]
16. Analysing early liver dysfunction after bone marrow transplantation.
Storek J; Gale RP; Goldstein L
Transpl Immunol; 1993; 1(3):163-71. PubMed ID: 8081774
[No Abstract] [Full Text] [Related]
17. [Veno-occlusive disease after bone marrow transplantation: preventive effect of heparin].
Parquet N; Devergie A; Socié G; Ribaud P; Espérou H; Gluckman E
Ann Med Interne (Paris); 1997; 148(2):132-5. PubMed ID: 9238437
[TBL] [Abstract][Full Text] [Related]
18. A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantation.
Terra SG; Spitzer TR; Tsunoda SM
Pharmacotherapy; 1997; 17(5):929-37. PubMed ID: 9324182
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
Remberger M; Ringdén O
Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation.
Testa S; Manna A; Porcellini A; Maffi F; Morstabilini G; Denti N; Macchi S; Rosti G; Porcellini G; Cassi D; Ferrari L
Bone Marrow Transplant; 1996 Aug; 18(2):383-8. PubMed ID: 8864450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
